Skip to main content

Advertisement

Log in

Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin’s disease

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Novellino L, Longoni M, Spinelli L, Andretta M, Cozzi M, Failace G (1994) ‘Extended’ thymectomy without sternothomy, performed by cervicothomy and thoracoscopic technique in the treatment of myasthenia gravis. Int Surg 79:38–381

    Google Scholar 

  2. Engel AG (1994) Acquired autoimmune myasthenia gravis. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1769–97

    Google Scholar 

  3. Muller-Hermelink HK, Marx A, Kirchner T (1996) Thymus. In: Dùmianov I, Lindner J (eds) Anderson’s Pathology. St Louis, Mosby Year-Book, pp 1218–1243

    Google Scholar 

  4. Marx A, Muller-Hermelink HK (1999) From basic immunobiology to the upcoming WHO-classification of tumors of the thymus. The Second Conference on Biological and Clinical Aspects of the Thimic Epithelial Tumors and related recent developments. Pathol Res Pract 195:515–533

    PubMed  CAS  Google Scholar 

  5. Null J, LiVolsi VA, Glenn WWL (1977) Hodgkin’s disease of the thymus (granulomatous thymoma) and myasthenia gravis. Am J Clin Pathol 67:521–525

    PubMed  CAS  Google Scholar 

  6. Padua L, Palmisani MT, Di Trapani G, Evoli A, Larrocca LM, Tonali P (1994) Myasthenia gravis and thymic Hhodgkin’s disease associated in one patient with familial lymphoproliferative disorders. Clin Neuropathol 13:292–94

    PubMed  CAS  Google Scholar 

  7. Tranchant C, Racamier E, Warter JM (1993) Seronegative myasthenia gravis and familial Hodgkin’s disease. Eur Neurol 33:17–19

    PubMed  CAS  Google Scholar 

  8. Quilichini R, Fuentes P, Metge G, Lafeuillade A, Albatro J (1994) Syndrome myasthenique revelateur d’une maladie de Hodgkin. Rev Neurol (Paris) 150(1):81–82

    CAS  Google Scholar 

  9. Abrey LE, Askanas V (1995) Association of myasthenia gravis with extrathymic Hodgkin’s lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy. Neurology 45:1019

    PubMed  CAS  Google Scholar 

  10. Aarli J. A. Clinical immunology of thymic tumors in patients with myasthenia gravis. In: Marx A, Muller-Hermelink HK (eds) Epithelial tumors of the thymus. Pathology, Biology, Treatment Plenum Press, New York, pp 265–269

  11. Bataller L, Dalmau J (2003) Paraneo-plastic neurologic syndromes: approaches to diagnosis and treatment Sem. Neurol 23(2):215–224

    Article  Google Scholar 

  12. Maggio E, Van der Berg A, Diepstra A, Kluiver J, Visser L, Popema S (2002) Chemokines, cytokines and their receptors in Hodgkin’s lymphoma cell lines and tissues. Ann Oncol 13:52–56

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. T. Ferrò.

Additional information

Received in revised form: 24 November 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrò, M., Riccardi, T., Montanelli, A. et al. Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin’s disease. J Neurol 253, 1241–1242 (2006). https://doi.org/10.1007/s00415-006-0171-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0171-6

Keywords

Navigation